Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liposomal vitamin C is a formulation of ascorbic acid (vitamin C) encapsulated within lipid-based vesicles known as liposomes. This delivery system is designed to enhance the bioavailability and stability of vitamin C compared to conventional oral forms, as the liposomal structure protects the nutrient from degradation in the digestive tract and facilitates absorption across cell membranes. It is primarily used as a nutraceutical for antioxidant support, immune function, and addressing vitamin C deficiency. In clinical research, it is being investigated for its potential to enhance the efficacy of chemotherapy (e.g., in combination with ATR inhibitors like ceralasertib) by increasing intracellular concentrations and promoting oxidative stress-induced cell death, specifically through the activation of ferroptotic pathways in cancer cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on liposomal vitamin C (AronPharma).